218 related articles for article (PubMed ID: 31796883)
1. Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis.
Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Natarajan M; Kornfeld H; Babu S
Sci Rep; 2019 Dec; 9(1):18217. PubMed ID: 31796883
[TBL] [Abstract][Full Text] [Related]
2. Heightened systemic levels of anti-inflammatory cytokines in pulmonary tuberculosis and alterations following anti-tuberculosis treatment.
Moideen K; Kumar NP; Bethunaickan R; Banurekha VV; Nair D; Babu S
Cytokine; 2020 Mar; 127():154929. PubMed ID: 31811994
[TBL] [Abstract][Full Text] [Related]
3. Altered Systemic Adipokine Levels in Pulmonary Tuberculosis and Changes following Treatment.
Moideen K; Kumar NP; Nair D; Banurekha VV; Babu S
Am J Trop Med Hyg; 2018 Oct; 99(4):875-880. PubMed ID: 30182920
[TBL] [Abstract][Full Text] [Related]
4. Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis.
Kumar NP; Banurekha VV; Nair D; Babu S
PLoS One; 2016; 11(1):e0146318. PubMed ID: 26727122
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietins as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis.
Kumar NP; Velayutham B; Nair D; Babu S
Int J Tuberc Lung Dis; 2017 Jan; 21(1):93-99. PubMed ID: 28157471
[TBL] [Abstract][Full Text] [Related]
6. Altered circulating levels of B cell growth factors and their modulation upon anti-tuberculosis treatment in pulmonary tuberculosis and tuberculous lymphadenitis.
Kathamuthu GR; Moideen K; Banurekha VV; Nair D; Sridhar R; Baskaran D; Babu S
PLoS One; 2018; 13(11):e0207404. PubMed ID: 30427928
[TBL] [Abstract][Full Text] [Related]
7. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis.
Kathamuthu GR; Kumar NP; Moideen K; Nair D; Banurekha VV; Sridhar R; Baskaran D; Babu S
Front Immunol; 2020; 11():419. PubMed ID: 32218787
[TBL] [Abstract][Full Text] [Related]
8. Plasma heme oxygenase-1 levels distinguish latent or successfully treated human tuberculosis from active disease.
Andrade BB; Pavan Kumar N; Mayer-Barber KD; Barber DL; Sridhar R; Rekha VV; Jawahar MS; Nutman TB; Sher A; Babu S
PLoS One; 2013; 8(5):e62618. PubMed ID: 23671613
[TBL] [Abstract][Full Text] [Related]
9. Associations between systemic inflammation, mycobacterial loads in sputum and radiological improvement after treatment initiation in pulmonary TB patients from Brazil: a prospective cohort study.
Mesquita ED; Gil-Santana L; Ramalho D; Tonomura E; Silva EC; Oliveira MM; Andrade BB; Kritski A;
BMC Infect Dis; 2016 Aug; 16():368. PubMed ID: 27494953
[TBL] [Abstract][Full Text] [Related]
10. Coexistent Helminth Infection-Mediated Modulation of Chemokine Responses in Latent Tuberculosis.
Rajamanickam A; Munisankar S; Bhootra Y; Dolla CK; Nutman TB; Babu S
J Immunol; 2019 Mar; 202(5):1494-1500. PubMed ID: 30651341
[TBL] [Abstract][Full Text] [Related]
11. Malnutrition is associated with diminished baseline and mycobacterial antigen - stimulated chemokine responses in latent tuberculosis infection.
Anuradha R; Munisankar S; Bhootra Y; Kumar NP; Dolla C; Babu S
J Infect; 2018 Nov; 77(5):410-416. PubMed ID: 29777718
[TBL] [Abstract][Full Text] [Related]
12. Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary Tuberculosis.
Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Nair D; Banurekha VV; Sivakumar S; Hissar S; Kornfeld H; Babu S
Clin Infect Dis; 2021 Nov; 73(9):e3419-e3427. PubMed ID: 32766812
[TBL] [Abstract][Full Text] [Related]
13. Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study.
Vinhaes CL; Oliveira-de-Souza D; Silveira-Mattos PS; Nogueira B; Shi R; Wei W; Yuan X; Zhang G; Cai Y; Barry CE; Via LE; Fukutani KF; Andrade BB; Mayer-Barber KD
Cytokine; 2019 Nov; 123():154759. PubMed ID: 31226436
[TBL] [Abstract][Full Text] [Related]
14. Plasma Proinflammatory Cytokines Are Markers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis.
Kumar NP; Moideen K; Banurekha VV; Nair D; Babu S
Open Forum Infect Dis; 2019 Jul; 6(7):ofz257. PubMed ID: 31281858
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress, antioxidant status and lipid profile in pulmonary tuberculosis patients before and after anti-tubercular therapy.
Vidhya R; Rathnakumar K; Balu V; Pugalendi KV
Indian J Tuberc; 2019 Jul; 66(3):375-381. PubMed ID: 31439183
[TBL] [Abstract][Full Text] [Related]
16. Heightened Systemic Levels of Neutrophil and Eosinophil Granular Proteins in Pulmonary Tuberculosis and Reversal following Treatment.
Moideen K; Kumar NP; Nair D; Banurekha VV; Bethunaickan R; Babu S
Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29632246
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
[TBL] [Abstract][Full Text] [Related]
18. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
[TBL] [Abstract][Full Text] [Related]
19. Diminished plasma levels of common γ-chain cytokines in pulmonary tuberculosis and reversal following treatment.
Kumar NP; Banurekha VV; Nair D; Babu S
PLoS One; 2017; 12(4):e0176495. PubMed ID: 28448542
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 Expression in Monocytes Correlates with Bacterial Burden and Treatment Outcomes in Active Pulmonary Tuberculosis.
Pan SW; Shu CC; Huang JR; Lee CC; Tseng YH; Hung JJ; Hsu PK; Chen NJ; Su WJ; Feng JY; Chen YM
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
